Thomale J - Search Results

1

p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.

Gutekunst M, Oren M, Weilbacher A, Dengler MA, Markwardt C, Thomale J, Aulitzky WE, van der Kuip H. Gutekunst M, et al. Among authors: thomale j. PLoS One. 2011 Apr 21;6(4):e19198. doi: 10.1371/journal.pone.0019198. PLoS One. 2011. PMID: 21532991 Free PMC article.

2

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.

Usanova S, Piée-Staffa A, Sied U, Thomale J, Schneider A, Kaina B, Köberle B. Usanova S, et al. Among authors: thomale j. Mol Cancer. 2010 Sep 16;9:248. doi: 10.1186/1476-4598-9-248. Mol Cancer. 2010. PMID: 20846399 Free PMC article.

3

Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts.

Eicher C, Dewerth A, Thomale J, Ellerkamp V, Hildenbrand S, Warmann SW, Fuchs J, Armeanu-Ebinger S. Eicher C, et al. Among authors: thomale j. Br J Cancer. 2013 Feb 5;108(2):334-41. doi: 10.1038/bjc.2012.539. Epub 2012 Dec 20. Br J Cancer. 2013. PMID: 23257893 Free PMC article.

4

Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells.

Materna V, Liedert B, Thomale J, Lage H. Materna V, et al. Among authors: thomale j. Int J Cancer. 2005 Jun 20;115(3):393-402. doi: 10.1002/ijc.20899. Int J Cancer. 2005. PMID: 15688364 Free article.

5

Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells.

Böckelmann L, Starzonek C, Niehoff AC, Karst U, Thomale J, Schlüter H, Bokemeyer C, Aigner A, Schumacher U. Böckelmann L, et al. Among authors: thomale j. Histochem Cell Biol. 2020 May;153(5):367-377. doi: 10.1007/s00418-020-01857-x. Epub 2020 Mar 3. Histochem Cell Biol. 2020. PMID: 32125512 Free PMC article.

6

Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells.

Melnikova M, Wauer US, Mendus D, Hilger RA, Oliver TG, Mercer K, Gohlke BO, Erdmann K, Niederacher D, Neubauer H, Buderath P, Wimberger P, Kuhlmann JD, Thomale J. Melnikova M, et al. Among authors: thomale j. Mol Oncol. 2020 Apr;14(4):686-703. doi: 10.1002/1878-0261.12648. Epub 2020 Mar 10. Mol Oncol. 2020. PMID: 32037720 Free PMC article.

7

ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma.

Bretz AC, Gittler MP, Charles JP, Gremke N, Eckhardt I, Mernberger M, Mandic R, Thomale J, Nist A, Wanzel M, Stiewe T. Bretz AC, et al. Among authors: thomale j. Nucleic Acids Res. 2016 Apr 20;44(7):3204-18. doi: 10.1093/nar/gkw036. Epub 2016 Jan 26. Nucleic Acids Res. 2016. PMID: 26819410 Free PMC article.

8

Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.

Keitel U, Scheel A, Thomale J, Halpape R, Kaulfuß S, Scheel C, Dobbelstein M. Keitel U, et al. Among authors: thomale j. Oncotarget. 2014 Dec 15;5(23):11778-91. doi: 10.18632/oncotarget.2634. Oncotarget. 2014. PMID: 25473892 Free PMC article.

9

Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a Tp53 Context-Specific Manner.

Jokić M, Vlašić I, Rinneburger M, Klümper N, Spiro J, Vogel W, Offermann A, Kümpers C, Fritz C, Schmitt A, Riabinska A, Wittersheim M, Michels S, Ozretić L, Florin A, Welcker D, Akyuz MD, Nowak M, Erkel M, Wolf J, Büttner R, Schumacher B, Thomale J, Persigehl T, Maintz D, Perner S, Reinhardt HC. Jokić M, et al. Among authors: thomale j. Mol Cancer Res. 2016 Nov;14(11):1110-1123. doi: 10.1158/1541-7786.MCR-16-0094. Epub 2016 Aug 11. Mol Cancer Res. 2016. PMID: 27514406

10

Spongean alkaloids protect rat kidney cells against cisplatin-induced cytotoxicity.

Funk F, Krüger K, Henninger C, Wätjen W, Proksch P, Thomale J, Fritz G. Funk F, et al. Among authors: thomale j. Anticancer Drugs. 2014 Sep;25(8):917-29. doi: 10.1097/CAD.0000000000000119. Anticancer Drugs. 2014. PMID: 24820908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page